Vienna, Austria

Herwig Igel

USPTO Granted Patents = 1 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Herwig Igel: Innovator in Plasma Protein Medicaments

Introduction

Herwig Igel is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicine, particularly in the development of plasma protein-containing medicaments. His innovative approach has led to advancements that benefit patients requiring such treatments.

Latest Patents

Herwig Igel holds a patent for a "Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals." This patent describes a method of preparing a medicament from citrated plasma or a citrate-containing plasma fraction. The resulting medicament is substantially free from undesired metals, ensuring a safer product for medical use. He has 1 patent to his name.

Career Highlights

Igel's career has been marked by his work at Baxter Aktiengesellschaft, a leading company in the healthcare sector. His role has allowed him to focus on innovative solutions that enhance the quality of medical treatments. His expertise in plasma protein technology has positioned him as a key figure in this specialized field.

Collaborations

Throughout his career, Igel has collaborated with notable colleagues, including Wolfgang Teschner and Yendra Linnau. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Herwig Igel's contributions to the field of plasma protein medicaments highlight his dedication to improving medical treatments. His innovative patent and collaborative efforts with colleagues underscore his impact on healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…